Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1100 of 3546 entries
View as:

A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI)

Phase: N/A Priority: Normal
NCT ID: NCT02184611 Org: User:
Start: 05/09/16 End: 11/08/17 Due: 11/08/18

A Study of Belimumab in Chinese Pediatric Participants With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT05917288 Org: User:
Start: 07/07/23 End: 10/30/24 Due: 10/30/25

Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.

Phase: N/A Priority: Normal
NCT ID: NCT00327522 Org: User:
Start: 06/30/06 End: - Due: -

Rechallenge, Potential Drug Induced Liver Injury (Kaiser)

Phase: N/A Priority: Normal
NCT ID: NCT01584765 Org: User:
Start: 02/29/12 End: 04/30/13 Due: 04/30/14

A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria

Phase: N/A Priority: Normal
NCT ID: NCT02563496 Org: User:
Start: 02/06/17 End: 02/17/20 Due: 02/17/21

Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT05382312 Org: User:
Start: 07/26/22 End: 11/01/24 Due: 11/01/25

An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT06666491 Org: User:
Start: 11/13/24 End: 07/06/26 Due: 07/06/27

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age

Phase: N/A Priority: Normal
NCT ID: NCT00808444 Org: User:
Start: 01/05/09 End: 11/02/09 Due: 11/02/10

Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05133830 Org: User:
Start: 11/23/21 End: 05/31/22 Due: 05/31/23

Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)

Phase: N/A Priority: Normal
NCT ID: NCT01390792 Org: User:
Start: 01/31/07 End: 05/31/09 Due: 05/31/10

Study to Determine the Effect of 14 Days Dosing With Darapladib (SB-480848) on Carotid Plague Composition in Patients With Planned Carotid Endarterectomy

Phase: N/A Priority: Normal
NCT ID: NCT01916720 Org: User:
Start: 01/31/03 End: 07/31/03 Due: 07/31/04

A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo

Phase: N/A Priority: Normal
NCT ID: NCT01072149 Org: User:
Start: 01/01/10 End: 07/01/10 Due: 07/01/11

A Study to Evaluate the Effect of Two Different Repeat Doses of GSK2190915 on the QTc Interval.

Phase: N/A Priority: Normal
NCT ID: NCT01721135 Org: User:
Start: 09/30/10 End: 12/31/14 Due: 12/31/15

Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan

Phase: N/A Priority: Normal
NCT ID: NCT04551989 Org: User:
Start: 12/11/20 End: 04/27/23 Due: 04/27/24

WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT01636726 Org: User:
Start: 03/31/12 End: 07/31/14 Due: 07/31/15

Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00097409 Org: User:
Start: 12/31/04 End: 05/31/07 Due: 05/31/08

Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils

Phase: N/A Priority: Normal
NCT ID: NCT01366521 Org: User:
Start: 02/28/11 End: 03/31/12 Due: 03/31/13

Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)

Phase: N/A Priority: Normal
NCT ID: NCT02135666 Org: User:
Start: 05/31/15 End: 10/31/19 Due: 10/31/20

A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607

Phase: N/A Priority: Normal
NCT ID: NCT02737007 Org: User:
Start: 04/18/16 End: 05/12/16 Due: 05/12/17

Long-term Study Of Paroxetine in Women and Men

Phase: N/A Priority: Normal
NCT ID: NCT00264654 Org: User:
Start: 10/31/05 End: 11/30/05 Due: 11/30/06

Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00694993 Org: User:
Start: 12/17/07 End: 05/26/08 Due: 05/26/09

Dose-Escalation Study of GSK2126458

Phase: N/A Priority: Normal
NCT ID: NCT00972686 Org: User:
Start: 08/31/09 End: 03/31/15 Due: 03/31/16

A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers

Phase: N/A Priority: Normal
NCT ID: NCT01587703 Org: User:
Start: 03/28/12 End: 07/29/19 Due: 07/29/20

Evaluation of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure

Phase: N/A Priority: Normal
NCT ID: NCT03103906 Org: User:
Start: 05/10/17 End: 07/19/17 Due: 07/19/18

Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)

Phase: N/A Priority: Normal
NCT ID: NCT00989612 Org: User:
Start: 10/01/09 End: 04/19/10 Due: 04/19/11